These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33887393)

  • 41. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation and characterization of gelatin surface modified PLGA microspheres.
    Tsung MJ; Burgess DJ
    AAPS PharmSci; 2001; 3(2):E11. PubMed ID: 11741261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Release kinetics of fluorescent dyes from PLGA nanoparticles in retinal blood vessels: In vivo monitoring and ex vivo localization.
    Zhang E; Zhukova V; Semyonkin A; Osipova N; Malinovskaya Y; Maksimenko O; Chernikov V; Sokolov M; Grigartzik L; Sabel BA; Gelperina S; Henrich-Noack P
    Eur J Pharm Biopharm; 2020 May; 150():131-142. PubMed ID: 32151727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration.
    Yang H; Tyagi P; Kadam RS; Holden CA; Kompella UB
    ACS Nano; 2012 Sep; 6(9):7595-606. PubMed ID: 22876910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Poly(D,L-lactic-co-glycolic acid)-based artesunate nanoparticles: formulation, antimalarial and toxicity assessments.
    Dauda K; Busari Z; Morenikeji O; Afolayan F; Oyeyemi O; Meena J; Sahu D; Panda A
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):977-985. PubMed ID: 29119735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraductal Drug Delivery to the Breast: Effect of Particle Size and Formulation on Breast Duct and Lymph Node Retention.
    Joseph MK; Islam M; Reineke J; Hildreth M; Woyengo T; Pillatzki A; Baride A; Perumal O
    Mol Pharm; 2020 Feb; 17(2):441-452. PubMed ID: 31886676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation of Poly[lactic-co-glycolic] Acid Nanospheres and Its Role in Hepatoma Cells.
    Shi Z; Li J; Liang H; Hu H; Jiang H
    J Nanosci Nanotechnol; 2021 Feb; 21(2):977-986. PubMed ID: 33183433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months.
    Gu B; Papadimitrakopoulos F; Burgess DJ
    J Control Release; 2018 Nov; 289():35-43. PubMed ID: 30261203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
    Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
    Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
    Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
    Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
    Samkange T; D'Souza S; Obikeze K; Dube A
    J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sterilized ibuprofen-loaded poly(D,L-lactide-co-glycolide) microspheres for intra-articular administration: effect of gamma-irradiation and storage.
    Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
    J Microencapsul; 2004 Sep; 21(6):653-65. PubMed ID: 15762322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
    Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
    J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice.
    Roy P; Das S; Auddy RG; Saha A; Mukherjee A
    Pharm Res; 2013 May; 30(5):1252-62. PubMed ID: 23319171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.